Sacklers Increase Purdue Pharma Bankruptcy Settlement Contribution to $6.5 Billion from $6 Billion for Opioid Lawsuits

Jan 13, 2025, 11:35 AM

Members of the Sackler family, owners of Purdue Pharma, have agreed to increase their total contribution to a new bankruptcy settlement related to opioid lawsuits. The revised contribution will amount to approximately $6.5 billion, up from $6 billion under a previous plan. This adjustment comes as part of ongoing legal efforts to address the financial repercussions of the opioid crisis. Reports indicate that the Sacklers' overall wealth has increased since Purdue's bankruptcy filing, attributed to the appreciation of their investment assets and financial holdings.